Director Share Dealings - Braveheart Bio Inc (BRVE)

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

≈ Figures for the value of trade may not add up due to rounding.

Recent deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
7 August 2026	ORBIMED ADVISORS LLCInvestment Management Company	Buy Regular purchase transaction	1,666,667	$18.00	$30,000,006.00	11,901,826
7 August 2026	FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF UAVenture Capital	Buy Regular purchase transaction	1,920,000	$18.00	$34,560,000.00	11,640,546
7 August 2026	AH BIO FUND IV LPVenture Capital	Buy Regular purchase transaction	1,100,000	$18.00	$19,800,000.00	10,232,420
7 August 2026	FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF UAVenture Capital	Buy Regular purchase transaction	1,680,000	$18.00	$30,240,000.00	10,185,478
7 August 2026	Travis MurdochChairman/CEO	Buy Regular purchase transaction	83,333	$18.00	$1,499,994.00	2,940,670
7 August 2026	Christopher A (Chris) ViehbacherChairman of the Board	Buy Regular purchase transaction	83,333	$18.00	$1,499,994.00	609,519
7 August 2026	David I MalekDirector	Buy Regular purchase transaction	4,166	$18.00	$74,988.00	533,845
7 August 2026	James Paul RickeyCFO	Buy Regular purchase transaction	27,777	$18.00	$499,986.00	520,927
7 August 2026	Michele A AndersonChief Level Officer	Buy Regular purchase transaction	1,111	$18.00	$19,998.00	332,161
7 August 2026	ORBIMED ADVISORS LLCInvestment Management Company	Buy Regular purchase transaction	273,333	$18.00	$4,919,994.00	273,333

5 most significant deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
7 August 2026	FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF UAVenture Capital	Buy Regular purchase transaction	1,920,000	$18.00	$34,560,000.00	11,640,546
7 August 2026	FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF UAVenture Capital	Buy Regular purchase transaction	1,680,000	$18.00	$30,240,000.00	10,185,478
7 August 2026	ORBIMED ADVISORS LLCInvestment Management Company	Buy Regular purchase transaction	1,666,667	$18.00	$30,000,006.00	11,901,826
7 August 2026	AH BIO FUND IV LPVenture Capital	Buy Regular purchase transaction	1,100,000	$18.00	$19,800,000.00	10,232,420
7 August 2026	ORBIMED ADVISORS LLCInvestment Management Company	Buy Regular purchase transaction	273,333	$18.00	$4,919,994.00	273,333

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.